SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " regulatory " 406 found 🔀 AI-powered Shuffle
Massachusetts Governor Signs Cannabis Bill, Changing Purchase Limits, Regulatory Scheme
Gov. Maura Healey approved the plan to overhaul the Cannabis Control Commission, encourage business growth and broaden consumer access.
Secretary Kennedy Appoints Casey B. Mulligan as HHS Chief Economist and Regulatory Officer
HHS appoints Casey B. Mulligan, PhD, as Chief Economist and Chief Regulatory Officer.
Flutter Entertainment Stock (FLUT) Opinions on Citi Downgrade
Citi Downgrade Triggers Alarm: Social media erupted today after Citigroup double-downgraded Flutter Entertainment to sell, citing mounting U.S. business risks for its FanDuel unit. Users dissected concerns over slowing growth, intensifying competition, and potential regulatory hurdles. The stock tumbled in premarket trading amid the fresh bearish call.Profitability Doubts Mount: Conversations highlighted slashed EBITDA forecasts and reduced buyba
Science and standards: a comprehensive guide to radiological protection
New book provides an essential guide to the science, regulatory landscape and real world practice of radiological protection
EPA, DDA, Renew Pledge to First State Farming, Environmental Health with Memorandum of Understanding - State of Delaware News
The MOU covers topics from communication and education to environmental stewardship, funding opportunities and regulatory programs.
CEPI and PAHO expand partnership to strengthen regulatory systems and vaccine safety across the Americas
The agreements build on a broader five-year Memorandum of Understanding, signed in 2024.
3L Rachel Sadler Charts Path in Brain Health, Technology, and Policy Through UC Law SF’s Health Law Concentration - UC Law San Francisco (Formerly UC Hastings)
3L Rachel Sadler studies health law and policy at UC Law SF while researching the legal implications of neurotechnology and other emerging tools that may affect human cognition. 3L student Rachel Sadler shares how UC Law SF’s Health Law Concentration prepared her for a career focused on the intersection of brain health, government policy, and technology. Gained a detailed understanding of how U.S. health care is regulated and where policy reform is needed through coursework and research. Interned with state and federal agencies that regulate health care services and worked with a major health care provider’s bioethics department. Plans to pursue a career focused on protecting cognitive liberty and mental privacy as new technologies reshape healthcare. 3L Rachel Sadler: The Health Law Concentration has given me fluency in one of the most complex regulated industries and the tools to become an effective advocate for better health policy. Before coming to law school, I spent a decade teaching and working with teachers and administrators on high school programming for multilingual learners. Healthcare kept emerging as the most powerful driver of student outcomes. I wanted to understand how to make effective policy change in this area and how to use existing law to defend people’s health rights in California. Through the concentration’s coursework, I gained a sophisticated understanding of how U.S. healthcare is regulated. I also learned where the pressure points for reform exist. The courses gave me space to develop what became my central research interest: how law and policy can be built to protect human cognition and healthy brain development, particularly regarding new technologies such as generative AI and neurotechnology. The health law faculty were instrumental in that process, genuinely invested in helping me and other students define and pursue our own intellectual vision. During law school, I interned at the General Counsel’s Office for Region IX of the U.S. Department of Health and Human Services. I also externed at the California Department of Justice’s Health, Education and Welfare Division. Additionally, I externed at Kaiser Permanente Northern California’s Bioethics Department. Alongside those placements, I conducted extensive independent research on mental privacy and emerging neurotechnology, working closely with Professors Emily Murphy and George Horvath. That research became the throughline of my law school experience and the foundation of my current policy focus. I must also credit Nicole Ozer of the Center for Constitutional Democracy (CCD), whose deep knowledge of California privacy law and the public-interest privacy landscape deeply informed my work. I currently serve a research assistant with the CCD, where I spearhead the development of K-12 educational resources in partnership with law faculty and students. I’ve found UC Law SF to be an ideal place for second-career, nontraditional students. There is a tremendous diversity of life and career experience here, and I felt fully welcomed into the community, despite returning as a student at a different stage of life. I came to law school wanting to promote equity in California’s healthcare system. I am leaving with a sharper and more specific ambition: to build a policy career focused on protecting cognitive liberty and mental privacy from technological intrusion. This is both an urgent and underserved area of law, and I want to be part of defining this landscape going forward. Whether as a practicing attorney or a policy advisor, I plan to work on these issues after law school. I strongly recommend UC Law SF and the Health Law Concentration. When I arrived in law school, I worried the concentration would be narrow and that my non-clinical background would be a disadvantage. The opposite was true. The health law faculty thinks about health expansively, encompassing social determinants of health, structural inequity, and emerging technologies alongside the regulatory mechanics of the industry. The faculty are accessible, intellectually generous, and genuinely invested in students’ development. I found my research vision here, and I deeply appreciate the concentration’s role in this. The Evidence of Success series highlights UC Law SF students as they share how the College’s opportunities equip them with the experience, skills, and confidence to excel in the legal profession.
Comptroller Review Finds City's Small Business Forward Program Failed to Cut Red Tape or Limit Fines
New York, NY — A new review conducted by auditors of New York City Comptroller Mark Levine found the Small Business Forward program, aimed at easing regulatory and financial burdens on small businesses across the five boroughs, failed to achieve meaningful change for small businesses in New York City. Vague definitions, a lack...
IAM Union Members Gather to Bolster Political Action and Solidarity in Wisconsin
Delegates from the IAM Wisconsin State Council recently gathered in Madison for a three-day meeting, bringing together members from across the state. Discussions underscored regulatory and political challenges impacting collective bargaining, while reaffirming the need for solidarity and proactive engagement to strengthen workers’ rights. Gov. Tony Evers opened the conference with remarks and, joined by
Upcoming Tech and Sourcing Webinar on Digital Health
Join partner Ben Klaber and of counsels Ariel Seeley and Eric Pennesi on Thursday, April 9, 2026 from 12:00 to 1:00 pm ET for a discussion on innovations and trends in digital health. Topics will include artificial intelligence and connected devices, as well as data governance and regulatory developments.
FTC Announces New Health Care Task Force
In a development likely to ramp up regulatory pressure on an industry already under significant federal scrutiny, Federal Trade Commission (FTC) Chairman Andrew Ferguson recently directed leaders…
Coinbase clears key regulatory hurdle in bid to bolster its stablecoin business
Coinbase has received conditional approval from the U.S. Office of the Comptroller of the Currency (OCC) to operate as a trust bank, the company said Thursday.
Registrations open for São Paulo School of Advanced Science on Regulatory Governance
School at the Getulio Vargas Foundation (Brazil) covers emerging regulatory frontiers, including central banks in climate risk regulation and antitrust in digital markets. Apply by April 30.
The Bull Case For PENN Entertainment (PENN) Could Change Following Aurora Casino Relocation And Expansion
PENN Entertainment has opened the new US$360 million land-based Hollywood Casino Aurora across from Chicago Premium Outlets, nearly doubling its local workforce to about 700 people and preparing to transfer operations from its older riverboat site pending final regulatory approvals and funding support from Gaming and Leisure Properties and the City of Aurora. This expansion deepens PENN’s presence in the competitive Chicagoland casino corridor while highlighting its asset-light funding model...
Apple Intelligence Accidentally Goes Live in China Before Regulatory Approval
Apple accidentally started rolling out Apple Intelligence features in China before receiving regulatory approval, reports Bloomberg's Mark Gurman. Some Chinese users began seeing Apple Intelligence features listed as available and active in the Settings app on their iPhones, but Apple made no formal announcement. Gurman says that Apple is not planning to launch the feature imminently, and that its availability was a mistake. Apple has since removed the Apple Intelligence features.
Public health providers have to obey strict cyber security rules – so should private contractors
Recent data breaches damaged trust in New Zealand’s health system. A new cyber security strategy must ensure stricter regulatory oversight and mandatory audits.
AI regulation clashing with business lobby in Louisiana
Louisiana lawmakers have filed over 20 AI bills, but broader regulatory efforts face resistance from business groups and federal warnings.
NAIC Intensifies AI Regulatory Focus: What Health Insurance Payors Need to Know
The National Association of Insurance Commissioners (NAIC) is intensifying its oversight of how insurers use AI — and the pace of regulatory activity shows no signs of slowing. Over the past several…
Glyphosate: A story of science, risk, and nuance
In the summer of 2014, a California groundskeeper named Dewayne Johnson started noticing patches of raw, weeping skin spreading across his body. He had spent years applying Roundup, Monsanto’s glyphosate-based herbicide, for a school district, sometimes drenched in it when equipment malfunctioned. By 2014, he had a diagnosis: non-Hodgkin’s lymphoma. In 2018, a jury awarded him $289 million in damages, later reduced on appeal. Tens of thousands of lawsuits followed. The story hasn’t quieted down. It’s all over the internet, swinging between “this will kill you, buy organic” and “relax, you’re fear-mongering.” Some of that recent chatter stems from an Executive Order protecting glyphosate and its production, which set off intense infighting within the MAHA movement. Some of it reflects a deeper truth: Americans genuinely care about harmful chemicals in their environment (see poll below). And the conversation isn’t going anywhere, with a Supreme Court case involving Monsanto set for this April. Glyphosate (the active ingredient in Roundup) is one of the most widely used herbicides in the world. But does glyphosate cause cancer? And how much exposure is actually risky? With so much mistrust in institutions and corporations (and some genuine conflicts of interest), making sense of the actual scientific evidence is genuinely hard. Here is a translation of what the scientific evidence actually says. Does glyphosate cause harm? Glyphosate is an herbicide that kills most plants it contacts rather than targeting specific species. It works by blocking an enzyme pathway (EPSPS) that plants and many microorganisms need to produce essential amino acids. Without those amino acids, the plant can’t grow and dies. Glyphosate was first developed by Monsanto in the 1970s and became ubiquitous after the company introduced “Roundup Ready” crops in the 1990s. In 2024, Bayer removed glyphosate from residential Roundup-branded products due to litigation pressure. But today it is still the most widely used herbicide in the world. Farmers also discovered they could spray it directly on crops like oats, lentils, beans, and peas just before harvest to dry them out faster and make harvesting easier. Because of its widespread use, it’s obviously really important to understand if it’s harmful to humans. The key principle: The dose makes the poison The most important concept in toxicology is that “the dose makes the poison.” Sixteenth-century physician Paracelsus articulated what remains the foundational principle of toxicology: sola dosis facit venenum. Water will kill you if you drink enough of it. Aspirin saves lives at 81 milligrams and causes internal bleeding at higher chronic doses. So, at what dose is glyphosate poisonous? The LD50 in rats (the dose that kills half the test animals) is around 5,600 mg/kg body weight. Table salt is roughly 3,000 mg/kg. By that classic measure, glyphosate is less acutely toxic than salt. But some people are exposed to a lot of glyphosate through their work. And among the general public, there are many questions about low-dose, cumulative exposure from multiple sources over long periods. Does glyphosate cause health problems? Cancer Correlation maps are striking, with one analysis finding that 60% of counties that spray the most glyphosate have non-Hodgkin’s lymphoma rates above the national average. But correlation alone doesn’t establish cause, which is why animal and human studies matter. In animals: Rat studies are typically what most fear is rooted in, but most people don’t know the study details on the dosage given to rats. A pooled analysis of the 13 most rigorous rat studies found evidence that very high doses, around 55,000 times greater than typical food residue exposure, can cause certain cancers. In humans: One of the strongest studies followed 55,000 herbicide users over 20 years and found no overall increased cancer risk. There was one signal: among those with the highest use, rates of acute myeloid leukemia (AML) appeared elevated. A broader meta-analysis of 18 human studies also found no overall cancer risk, though a separate meta-analysis focused specifically on non-Hodgkin lymphoma found that people with high cumulative glyphosate exposure faced a 41% higher relative risk compared to those with low or no exposure. These human studies are observational studies (randomized controlled trials would be unethical), and meta-analyses are only as reliable as the studies they pool. But the story seems consistent: at very high exposure levels, there may be some cancer risk. But that’s about as far as the science currently takes us. Emerging research: gut and reproductive health Gut: Because glyphosate targets a pathway that exists in some gut bacteria, scientists have questioned whether it could affect the microbiome. In mice, a 2023 University of Iowa study found that glyphosate altered gut bacterial composition and raised markers of intestinal inflammation. A 2024 systematic review found similar patterns: disrupted gut bacteria and problems with the mucus layer that protects the intestinal wall in mice. Whether this translates to humans is an open question. The human gut is highly variable and resistant, and we don't yet have strong studies confirming the same effects in people. Reproductive health: Animal studies have found that glyphosate-based herbicides can interfere with reproductive hormones, including disrupting egg cell development in mice and reducing the number of eggs available in sheep’s ovaries. However, the doses used in these experiments were high, so it’s not yet clear whether the same effects would occur in humans. On the human side, a 2021 pilot study led by Mount Sinai researchers tested urine samples from pregnant women across the U.S. and found glyphosate in 95% of them. The study also found a possible connection between higher glyphosate exposure during pregnancy and a subtle physical difference measured in female newborns. That said, some connections weren’t statistically reliable and this was a small study. The researchers themselves said more and larger studies are needed before drawing firm conclusions. What do regulators say about glyphosate safety? In 2015, the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" (Group 2A). The classification is worth taking seriously. But, there’s an important distinction: IARC classifies hazard, meaning the potential to cause harm under some conditions. It does not assess risk, which accounts for actual exposure levels and the real-world probability of harm. The U.S. EPA, the European Food Safety Authority, Health Canada, and regulatory agencies in Australia and Japan have all concluded that glyphosate is “unlikely to be carcinogenic to humans” at realistic exposure levels. They’re asking a different question: given how much of this people actually encounter, what is the probability of harm? Your actual exposure is what determines your actual risk. What does glyphosate mean for your daily life? At the grocery store: Food residues are small. The EPA’s acceptable daily intake is 1.75 mg/kg of body weight per day. To hit that threshold from oatmeal alone, a 150-pound adult would need to eat roughly 50 pounds of oats every day. But this calculation addresses only one pathway (food), and we don’t yet have robust tools to measure people’s actual total exposure. If reducing exposure matters to you, organic certification prohibits synthetic herbicides, and organic oat products generally test at lower or undetectable levels. Either way, a diet rich in whole grains, conventional or organic, is far better for your health than one that omits them out of fear of residues. On the farm: Occupational exposure is orders of magnitude higher than consumer exposure. Farmers and farm workers who mix, load, and apply glyphosate-based herbicides, especially without protective equipment, face meaningfully different risk profiles. Proper PPE isn’t optional. Integrated weed management strategies that rotate chemical modes of action are also worth taking seriously, both for health and for long-term effectiveness. If you live near a farm: Spray drift is real. Concentrations near field edges can spike during and after application, particularly on windy days. This is an area where I think public health could really step up and empower rural communities with buffer zones, rather than placing the onus on individuals. But for now, knowing your local agricultural calendar and keeping windows closed during application are the first steps. Bottom line Dewayne Johnson was exposed to glyphosate at levels most people will never encounter, and a jury decided he deserved compensation. That outcome is not evidence that the oatmeal in your pantry is dangerous. But it is a reminder that the dose, the context, and the person doing the exposing all matter enormously. Glyphosate is a chemical tool with benefits, trade-offs, and genuine open scientific questions. Learning to hold that complexity without collapsing into panic or dismissal is, honestly, one of the most useful and hardest things to do in navigating modern health science. Love, YLE Your Local Epidemiologist (YLE) is founded and operated by Dr. Katelyn Jetelina, MPH PhD—an epidemiologist, wife, and mom of two little girls. Hannah Totte, MPH, is an epidemiologist and YLE Community Manager. YLE reaches more than 425,000 people in over 132 countries with one goal: “Translate” the ever-evolving public health science so that people will be well-equipped to make evidence-based decisions. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Ambani's Reliance Jio: businesses and investors of the IPO-bound firm
Indian billionaire Mukesh Ambani's Reliance Jio Platforms is gearing up to file papers seeking regulatory approvals for a Mumbai listing, in what is likely to be the biggest-ever stock offering in the country.
[VIDEO] Lucy Wang Featured in Business Interview TV Series
Watch a new Business Insurance interview with Lucy Wang, discussing how California's historic insurance regulatory reform has impacted the state's insurance market and rates in response to increasing wildfire exposure.
Illinois: Penn Entertainment's Hollywood Casino Aurora scheduled to open June 24
Penn Entertainment announced on Thursday that Hollywood Casino Aurora will open to the public on June 24, pending customary regulatory approvals. This will be the second new Penn property to... Read more »
PENN Entertainment Sets June 24 as Grand Opening Date for New Hollywood Casino Aurora in Illinois
WYOMISSING, Penn. & AURORA, Ill., March 19, 2026--PENN Entertainment, Inc. ("PENN" or the "Company") (Nasdaq: PENN) announced today that it expects to open the new land-based Hollywood Casino Aurora to the public on Wednesday, June 24, pending customary regulatory approvals. This will be the second all-new PENN property to open in the Chicagoland region following the grand opening of the land-based Hollywood Casino Joliet in August 2025.
Allina Health to join Sutter Health in $26B proposed merger
Sutter Health and Minneapolis-based Allina Health unveiled plans to join and form a 39-hospital, $26 billion revenue nonprofit health system. | The cross-regional proposed deal would create a 39-hospital nonprofit system and is expected to close before the end of the year, pending a definitive agreement and regulatory approvals.
A Look At PENN Entertainment (PENN) Valuation After Columbus Hotel And High Limit Gaming Expansion News
PENN Entertainment (PENN) is back on investors’ radar after announcing a 203-room hotel tower and an expanded high-limit table games room at Hollywood Casino Columbus, both pending regulatory approvals. See our latest analysis for PENN Entertainment. Despite the hotel and high limit room expansion plans and the recent earnings surprise in Q4 2025, sentiment around PENN has been mixed. A 21.68% 1 month share price return contrasts with a 16.27% 1 year total shareholder return decline and an...
Circle Bank Charter And Earnings Put USDC Business Model In Focus
Circle Internet Group (NYSE:CRCL) has received preliminary approval to form a national trust bank, giving its USDC stablecoin business a new regulatory footing. The company also reported strong quarterly earnings, supported by rising USDC adoption and new partnerships with Visa and BlackRock. Circle Internet Group is appearing on more investor radars, with NYSE:CRCL closing at $115.38 and posting a 99.4% return over the past 30 days. The stock is also up 13.2% over the past week and 38.2%...
Scientists discover ancient DNA “switches” hidden in plants for 400 million years
Scientists have uncovered an enormous hidden archive of plant DNA that has endured for more than 400 million years. By comparing hundreds of plant genomes, researchers identified more than 2.3 million regulatory DNA sequences that act like genetic switches, controlling when and how genes are activated. These sequences, known as conserved non-coding sequences (CNSs), were detected using a new computational tool called Conservatory.
Ohio: Penn Entertainment to open hotel tower at Hollywood Casino Columbus June 12
Penn Entertainment announced on Thursday that it expects to open its new state-of-the-art hotel tower at Hollywood Casino Columbus on June 12, pending customary regulatory approvals. The 203-room hotel represents... Read more »
Chinese companies race to hedge against a swinging yuan with regulatory encouragement
Chinese companies have rushed to derivatives for protection from currency exposure as a rising yuan has hurt some exporters for months and - more recently - the war in Iran has ramped up volatility.
Finding solutions for Oregon's business struggles
A business leader calls for major tax, land use and regulatory changes.
National Write Your Congressman Q1 2026 Index: Small Business Owners Call for Congressional Action on Spending, Regulatory Relief and Tariffs
National Write Your Congressman (NWYC), an organization that gives small businesses a voice in government, released its Q1 2026 Index, highlighting small business sentiment toward Congress, the U.S. economy, and federal policies affecting business.
‘LaPolitics:’ State’s new strategic plan targets energy growth
In an effort to bolster and grow a core of its overall business portfolio—the energy and process industries—Louisiana has overhauled and reorganized related regulatory departments and commissioned its first targeted strategic plan in two decades. Louisiana Economic Development commissioned the strategic plan, which zeroed in on the energy and process industries as the most lucrative […]
Businesses owned by minorities, women lobby to reauthorize federal program
Minority- and women-owned businesses are urging Congress to reauthorize the Disadvantaged Business Enterprise program, which helps them compete for federal contracts. Recent regulatory changes and legal challenges have raised concerns about the program’s future and effectiveness.
Trump Regulatory Czar Jeffrey Clark Leaves White House
Jeffrey B. Clark oversaw the dismantlement of government restrictions on greenhouse gas emissions and water and air pollution. He had also faced a criminal probe in connection with the 2020 election.
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2025 fiscal year ended December 31, 2025. Key Highlights: Regulatory Progress: Achieved positive clinical study results from the AD04-103 pharmacokinetics (P
3L Kevin Afiesh Learns to Translate Legal Risk Into Business Strategy as FinTech Extern - UC Law San Francisco (Formerly UC Hastings)
3L Kevin Afiesh strengthened his corporate and fintech skillset through an externship at Plaid, gaining real-world experience at the intersection of technology and financial services. 3L student Kevin Afiesh shares how UC Law San Francisco’s Corporate Counsel Externship provided immersive, practice-ready training inside Plaid’s in-house legal department. Reviewed and analyzed technology-focused agreements, including emerging AI provisions and liability terms Explored financial services regulation and data governance within a growth-stage company Learned how internal legal teams shape product, partnership, and compliance planning 3L student Kevin Afiesh: During my externship at Plaid, I worked with the in-house legal team supporting a rapidly growing company at the intersection of technology and financial services. My work focused primarily on corporate, commercial, and intellectual property matters. I helped review and analyze vendor and partnership agreements, paying close attention to emerging artificial intelligence-related provisions and risk allocation terms. I also investigated regulatory and compliance issues involving financial services and data governance, and I researched intellectual property litigation relevant to fintech companies. This work supported legal risk assessment to guide strategic decision making. I learned firsthand how an in-house legal team operates in a highly regulated, innovation-driven environment, where legal analysis is closely integrated with business decision making. I saw how attorneys balance legal risk with commercial priorities and how their advice shapes contracting, compliance, and intellectual property strategy. It reinforced that effective in-house lawyers need to understand both the law and the operational realities of the business. The experience also strengthened my ability to communicate complex legal concepts clearly to non-lawyers and to provide advice that is precise, practical, and commercially aware. Throughout my academic and professional journey, I’ve worked with technology companies at different stages. Plaid added a distinct perspective within the tech ecosystem, showing me how a growth-stage fintech company approaches regulatory complexity, innovation, and risk tolerance. This sharpened my ability to adapt to clients with different structures, priorities, and compliance needs. As I prepare to practice corporate law in the technology industry, this exposure has strengthened my ability to align legal advice with a company’s stage of growth, strategic objectives, and internal dynamics. I would absolutely recommend the Corporate Counsel Externship Program. Working directly with an in-house legal team provided a meaningful sense of day-to-day practice inside a technology company, and the attorneys at Plaid were generous with their time and mentorship. The classroom component was equally valuable. Professors Nira Geevargis and Scott Darling created a thoughtful environment where we reflected on our experiences, discussed real-world challenges, and developed practical skills that complemented our fieldwork. More broadly, UC Law San Francisco’s location offers a clear advantage for students interested in technology, corporate practice, and public-interest work. Proximity to courts, law firms, and innovative companies — combined with programs like the Corporate Counsel Externship and an extensive Bay Area alumni network — make it a strong option for students who want to build their careers in the region. The Evidence of Success series highlights UC Law SF students as they share how the college’s opportunities equip them with the experience, skills, and confidence to excel in the legal profession.
TITAN Group Completes the Acquisition of Traçim Cement in the Greater Istanbul Market
Regulatory News: Titan SA (Euronext Brussels, ATHEX and Euronext Paris, TITC) announces that, following all customary approvals, it has completed the acquisi...
Small Business Regulatory Review Board to conduct its first meeting on Maui, March 19
The Department of Business, Economic Development and Tourism (DBEDT) Small Business Regulatory Review Board will conduct its next monthly meeting on Maui on Thursday, March 19, 2026. The meeting begins at 1 p.m. at the Kalana O Maui Building, 200 S. High St., Ninth Floor, in Wailuku. It will also be available on Zoom. This […]
Apple Accidentally Leaks 'MacBook Neo,' Its Rumored Low-Cost Laptop
Apple apparently uploaded (and promptly deleted) a regulatory document to its website for a MacBook Neo. Will we see it at tomorrow's Apple event?
Apple Accidentally Leaks Potential Budget MacBook Ahead of Big Event
The 'MacBook Neo' just showed up in Apple's regulatory documents. Could this be the budget MacBook we've been waiting for?
Apple Accidentally Leaks 'MacBook Neo'
Apple appears to have prematurely revealed the name of its rumored lower-cost MacBook model, which is expected to be announced this Wednesday. A regulatory document for a "MacBook Neo" has appeared on Apple's website. Unfortunately, there are no further details or images available yet. Unfortunately, there are no further details or images available yet.
Universal Health Services Q4 Earnings Call Highlights
Universal Health Services (NYSE:UHS) executives said the company finished 2025 with “strong results,” pointing to revenue growth, higher profitability metrics, and continued share repurchases, while outlining a 2026 outlook that incorporates several policy and regulatory headwinds. On the company’s
Flutter Entertainment Reassesses Growth As FanDuel Predicts Faces Regulatory Tests
Flutter Entertainment, NYSE:FLUT, missed recent revenue expectations and issued guidance for 2026 that some investors view as cautious. The company has launched FanDuel Predicts, expanding into prediction markets at a time when regulators are paying closer attention to the sector. These moves come as competition in online wagering and prediction products intensifies, raising questions about Flutter Entertainment's next phase of growth. For shareholders, the backdrop is already challenging...
Capitol Recap: Lawmakers grapple with private equity in Vermont’s health care system
Private equity has established a much more significant footprint in Vermont's health care landscape than was previously widely known. That’s injected new urgency into the regulatory conversation in Montpelier — but also complicated it.
What The 2026 State Of The Union Signals For Small Business
What the 2026 State of the Union means for small businesses navigating delayed budgets, regulatory changes and economic pressure.
Healthcare Business Intelligence Market to Reach USD 20.04 Billion by 2035, Fueled by Value-Based Care Adoption and AI-Powered Analytics Innovation
Rising Demand for Predictive Analytics, Cloud-Based BI Platforms, and Regulatory Quality Reporting Requirements Accelerate Market Expansion Globally.Austin, United States, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Healthcare Business Intelligence Market Size & Growth Analysis: “According to SNS Insider, The Healthcare Business Intelligence Market size is estimated at USD 8.32 billion in 2025 and is expected to reach USD 20.04 billion by 2035, growing at a CAGR of 9.19% over 2026-2035.” The growth of the
Best Sole Trader Accounting Software (2026): Sage Awarded for Simplicity and Compliance in the UK by Better Business Advice
Sage has been recognised by Better Business Advice for its accounting software designed for UK sole traders, highlighting its role in helping individuals manage bookkeeping, meet HMRC requirements, and maintain accurate financial records in a changing regulatory environment.
Budget, housing, business development: Concord City Council sets its priorities
Responsible monetary decisions. Clear and widely disseminated communication with the public, especially on the city’s finances and taxes. Helping people keep their homes and find new ones. Regulatory and cultural changes to make it easier for businesses and development, and investments in the roads, sewers and other infrastructure to support them. These pursuits are what […]
California’s Strict Regulations May Frustrate Business Starts
Does California deserve its reputation as a state that is unfriendly to business? PPIC experts discuss new findings on California’s regulatory environment and its effect on business launches.
Singapore Alternative Lending Business Market Report 2026-2029: BNPL and Embedded Finance Market Intensifies as Atome, Grab PayLater and Shopee SPayLater Compete with Bank-Led Instalment Expansion
Key market opportunities in Singapore's alternative lending include BNPL standardization favoring accredited providers, embedding SME credit within digital ecosystems, tightening digital acquisition standards, and expanding private credit funding pathways. These shifts could enhance regulatory compliance, market reach, and investment potential. Singaporean Alternative Lending Market Singaporean Alternative Lending Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Singapore Alternative Lendin
What is the 'equal time' rule that Colbert says led CBS to pull his Talarico interview?
Stephen Colbert's comments that network executives pulled his interview with Democratic Texas Senate candidate James Talarico over fears it would violate regulatory guidance from the Trump administration has prompted a conversation about the rules governing how media outlets treat political coverage.
Stephen Colbert says CBS pulled candidate interview ahead of early voting in Texas
Late-night host Stephen Colbert said his interview with Democratic Texas Senate candidate James Talarico was pulled from Monday night's broadcast over network fears it would violate regulatory guidance from the Trump administration on giving equal time to political candidates.
Businesses Lean on Technology as Cross-Border Trade Grows More Uncertain, Avalara Finds
New research from Avalara, Inc., the agentic tax and compliance leader, shows that while businesses are eager to expand globally, fading confidence in stable trade rules is forcing many to slow or delay growth amid rising regulatory complexity, tariffs, and geopolitical volatility.
Miami Beach Adopts Major Deregulatory Policy to Attract Restaurants and Live Entertainment
Florida YIMBY says "Yes In My Backyard" to positive new development in Florida.
NKY business owners fear proposed alcohol fee bill could drive customers away
Proposed 4% regulatory fee on all alcohol sales draws opposition from small business owners
Rejecting science, Trump reverses conclusion that climate change is harming Americans
The 2009 endangerment finding affirms that carbon dioxide and other greenhouse gases pose a threat to human health and welfare. Its repeal marks one of the most significant deregulatory actions in U.S. history.
Point-of-Sale Finance Series: The New Regulatory Reality for Small Business Financing and Trade Credit — The Consumer Finance Podcast
NFIB Leads Coalition Urging Congress to Reduce Regulatory Burdens for Small Business
NFIB advocates for legislation to fulfill the intent of the Regulatory Flexibility Act
CVS Health Q4 Earnings Call Highlights
CVS Health (NYSE:CVS) highlighted what executives described as a year of operational and financial progress during the company’s fourth-quarter 2025 earnings call, while also addressing industry cost pressures, Medicare Advantage funding concerns, and the evolving regulatory backdrop for pharmacy be
KBC Group finalises acquisition of Business Lease Czech Republic and Slovakia
KBC Group NV, ČSOB Leasing Czech Republic, ČSOB Leasing Slovakia, and AutoBinck Group NV announce Today the successful closing of the agreement for ČSOB Leasing Czech Republic, ČSOB Leasing Slovakia to acquire 100% of the shares in Business Lease s.r.o. (“Business Lease Czech Republic”) and Business Lease Slovakia s.r.o. (“Business Lease Slovakia”). The transaction, originally announced on 23 October 2025, has received all necessary regulatory approvals, including from the Antimonopoly Office of
Asia-Pacific Digital Ad Spend Business Databook Report 2026: Market to Reach 489.3 Billion by 2029 - Platform Competition is Intensifying Across Performance and Video Budgets
Asia-Pacific's digital ad market is poised for growth driven by retail media, CTV adoption, AI in campaign execution, and privacy-led strategies. Regional platforms are expanding ad options, enhancing competition. Localization in tier-2 cities and regulatory adaptations are reshaping ad strategies. Asia-Pacific Digital Ad Spend Market Asia-Pacific Digital Ad Spend Market Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Asia-Pacific Digital Ad Spend Market Size & Forecast by Spend Value Across 100+
Uber Doubles Down on Türkiye with Agreement to Acquire Getir’s Delivery Business
ISTANBUL, February 09, 2026--Uber Technologies, Inc. (NYSE: UBER) and Mubadala Investment Company today announced an agreement for Uber to acquire Getir’s delivery portfolio in Türkiye, including food, grocery, retail, and water delivery, subject to regulatory approval and other closing conditions.
Regulating Digital Health Technologies
Randi Seigel examines the evolving regulatory landscape for digital health tools.
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and Novo threats.
Why colorectal cancer breaks the immune system’s rules
Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally explains why. Scientists discovered that these T cells aren’t all the same: one subtype actually helps keep tumors in check, while another shields cancer from immune attack. The balance between these “good” and “bad” cells can determine whether a tumor grows or shrinks.
China Consumer Loyalty Business Report 2026: A $35.65 Billion Market by 2030 from $18.46 Billion in 2025 - 88VIP, JD.com, Meituan Black Card, and WeChat Infrastructure Anchor Platform-Led Models
The Chinese loyalty market presents prime opportunities in embedded, platform-driven loyalty models and membership-based systems across various sectors. Integration into super-app ecosystems, leveraging data-driven personalization within regulatory constraints, and blending offline-to-online experiences are key growth avenues. Chinese Loyalty Market Chinese Loyalty Market Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The "China Loyalty Market Size & Forecast by Spend Value Across 100+ KPIs by Progra
Second House panel warms to Chase Tramont bill on heated tobacco regulatory change
The measure would establish a different taxing structure for heated tobacco products, which are considered a less harmful alternative to cigarettes.
HCPro Joins National Cooperative of Health Networks to Support Rural Healthcare Workforce Development
Chicago, IL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- HCPro, a leading provider of healthcare education and regulatory solutions, today announced its partnership with the National Cooperative of Health Networks Association (NCHN), reinforcing HCPro’s commitment to supporting rural and community healthcare organizations through practical, role-based workforce education. As a partner of NCHN, HCPro will contribute expertise and resources to help rural health leaders address ongoing workforce challenges,
Everbridge Recognized in Business Continuity Management Software Landscape, Q1 2026 Report by Independent Research Firm
VIENNA, Va., February 04, 2026--Everbridge, Inc., the global leader in High Velocity Critical Event Management (CEM) and national public warning solutions, today announced its inclusion in Forrester’s The Business Continuity Management Software Landscape, Q1 2026. The report reflects renewed urgency around business continuity as organizations face more frequent disruptions, rising operational risk, and expanding regulatory expectations tied to resilience and preparedness – areas Everbridge suppo
Johns Hopkins Health Plans Executive Elected Chair of Medicare Advantage Plan Alliance Compliance Forum
Melissa Mohon to Lead National Organization Dedicated to Improving Regulatory Compliance and Quality Care for Medicare BeneficiariesHANOVER, Md., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Melissa L. Mohon, Executive Director of Compliance, Privacy and Regulatory Affairs at Johns Hopkins Health Plans, has been elected Chair of the Medicare Advantage Plan Alliance (MAPA) Compliance Forum. In this role, Mohon will lead the national organization’s efforts to advance regulatory compliance and strengthen coll
CVS Health Faces Antitrust Scrutiny As Valuation Flags Undervaluation Risk
U.S. House Judiciary Committee alleges CVS Health restricted independent pharmacies from using competing digital pharmacy hubs. The investigation cites cease and desist letters and network rule changes as potential antitrust issues. CVS Health disputes the findings and says some policies have been revised. For investors watching CVS Health (NYSE:CVS), the focus is shifting to regulatory risk around how its pharmacy network operates. The company’s shares closed at $74.52, with a return of...
Pace(R) Earns Environmental Business Journal Award for Adding Respirable Crystalline Silica Testing
Company awarded Business Achievement Award for New Practice in 2025 MINNEAPOLIS, MINNESOTA / ACCESS Newswire / January 30, 2026 / Pace® Analytical Services, the preferred provider of regulatory testing and analytical laboratory services, and a Division ...
cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
cbdMD, Inc. (NYSE American: YCBD), a leading innovator in hemp-derived wellness products, today announced a strategic initiative to integrate and expand its regulatory science, safety, and intellectual property assets to establish a differentiated cannabinoid compliance and evidence platform aligned with evolving federal healthcare evaluation frameworks, including emerging CMS and CMMI innovation initiatives.
A Look At Flutter Entertainment’s Valuation As Downgrades And UK Regulatory Shifts Weigh On Sentiment
Why Flutter Entertainment’s boardroom and regulatory news matters for shareholders Flutter Entertainment (FLUT) has been under pressure recently, with the stock down about 20% over the past month and roughly 28% over the past 3 months, against a backdrop of changing analyst sentiment. Several banks and brokers have reassessed their views, with a string of downgrades and lower price targets highlighting concerns around short term headwinds. At the same time, UK regulatory developments and a...
CVS Health (CVS) Valuation Check As Regulatory Scrutiny And Legal Outcomes Draw Investor Focus
Regulatory and legal scrutiny is back in focus for CVS Health (CVS), as a U.S. House Judiciary Committee probe into its pharmacy benefit manager practices unfolds, while a separate class action over prescription drug pricing has been dismissed. See our latest analysis for CVS Health. For context, CVS Health shares now trade at US$82.68, with a 30 day share price return of 5.95% and a year to date share price return of 3.18%, while the 1 year total shareholder return of 59.48% reflects how...
These 3 Policy Moves Are Likely To Change Health Care for Older People
Two Trump administration regulatory rollbacks affect nursing home staffing and home care workers, and a new AI experiment in Medicare has alarmed eldercare advocates and congressional Democrats.
Ken Griffin says Biden-era regulations ‘exhausting’ on American businesses, 'cost the US economy dearly'
Citadel CEO Ken Griffin says Biden administration's regulatory policies created 'constant friction' for businesses, calling Trump's approach an 'extraordinary boom.'
Gov. Tina Kotek has a plan to boost Oregon businesses, but challenges remain steep
Lawmakers and business leaders in Oregon have argued the state's tax and regulatory landscape is too harsh for businesses. Gov. Tina Kotek has signaled she wants to change Oregon's business reputation.
3 Policy Moves Likely to Change Health Care for Older People
Two regulatory rollbacks, along with a new A.I. experiment in Medicare, raise some worrisome questions.
NCAA asks CFTC to suspend prediction markets
The NCAA asked a federal regulatory body to stop prediction markets from offering trades on college sports until more safeguards are in place.
Prof. Dorit Reiss Wins National Award for Distinguished Service in Health Law - UC Law San Francisco (Formerly UC Hastings)
Professor Dorit Reiss, who brings legal expertise to public health debates, has received a national award for her lasting contributions to the field as a scholar, policy adviser, and mentor. Faculty Who Lead: Dorit Reiss Professor Dorit Reiss receives the 2026 Distinguished Service Award from the AALS Section on Law, Medicine and Health Care. She is a leading expert on vaccine law, advising policymakers and providing expert analysis to journalists. Reiss mentors future health law scholars and combats misinformation online through evidence-based public education. Professor Dorit Reiss, a leading voice on vaccine law and policy, has won a national award recognizing her contributions to health law. She received the 2026 Distinguished Service Award from the Association of American Law Schools (AALS) Section on Law, Medicine and Health Care. Presented at the AALS Annual Meeting in January, the award honors sustained service to public health and the health law academy through advocacy, public education, and mentorship. In presenting the award, Professor Doron Dorfman of Seton Hall Law School, chair-elect of the AALS Section on Law, Medicine and Health Care, described Reiss as “a committed public health advocate who has used her expertise to influence vaccine policy, research, and practice at both the state and federal levels for nearly two decades.” Reiss leads a widely read vaccine law listserv that provides real-time updates on litigation, regulatory developments, advisory committee proceedings, and public comment opportunities. The resource has become an important tool for lawyers, scholars, journalists, and public health professionals tracking fast-moving developments in vaccine policy. Her service extends to policymaking as well. She has supported vaccine-related legislation in California, testified before the U.S. Senate Judiciary Committee on vaccine mandates and non-medical exemptions, and serves on the Parent Advisory Board of Voices for Vaccines, a parent-led organization focused on reducing vaccine-preventable disease. Dorfman also highlighted Reiss’ active role in robust debates over vaccine safety and related laws and policies. “She directly engages misinformation by responding to anti-vaccination claims on social media with careful, evidence-based rebuttals,” Dorfman said. As federal vaccine policy undergoes significant change, Reiss has become a trusted source for major national news outlets, including The New York Times, The Washington Post, and CNN, which regularly seek her expert analysis on new policies and decisions. Dorfman noted that Reiss is widely respected for her mentorship of health law faculty and scholars. “She is consistently generous with her time—approachable, willing to provide feedback, and a mentor to many in the field, including myself,” he said. At UC Law SF, Reiss brings the spirit of public service into the classroom, helping students understand how legal frameworks translate into real-world public health outcomes. She holds the James Edgar Hervey ’50 Chair of Litigation, a position that recognizes faculty excellence in the field of litigation. The Distinguished Service Award highlights her sustained commitment to evidence-based vaccine policy, public education, and mentorship during a pivotal time for public health law.
HTI 5 Proposal Signals Health IT Deregulation and FHIR-first Interoperability and Refines Information Blocking Rule
The new Health Data, Technology and Interoperability proposed rule (known as HTI-5) signals a significant deregulatory shift aimed at...
Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise
Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced a strategic partnership with McKinney Regulatory Science Advisors ("McKinney"), a premier FDA regulatory consulting firm specializing in nicotine and reduced-risk consumer products, to spearhead its regulatory submission strategy and solidify its commitment to scientific leadership in the oral pouch technology space.
Advancing Claude in healthcare and the life sciences
Introducing Claude for Healthcare with HIPAA-ready infrastructure, plus expanded Life Sciences tools for clinical trials and regulatory submissions. New connectors to CMS, Medidata, and ClinicalTrials.gov.
Advancing Claude in healthcare and the life sciences
Introducing Claude for Healthcare with HIPAA-ready infrastructure, plus expanded Life Sciences tools for clinical trials and regulatory submissions. New connectors to CMS, Medidata, and ClinicalTrials.gov.
Top 10 African countries with the most business-friendly environments in 2025
Rwanda, Morocco, Mauritius, and seven other African countries emerged as the continent’s top performers in the 2025 World Bank business environment rankings, demonstrating notable progress in regulatory reforms, operational efficiency, and governance
Real Chemistry Establishes RC Resolve, an Advisory Practice for Healthcare’s Most Critical Business, Regulatory and Value Inflection Points
NEW YORK, January 09, 2026--Real Chemistry launches RC Resolve, a healthcare advisory practice helping leaders navigate value inflection points.
Small Business Admin. Official Testifies on Regulatory Reform & Small Business Support
Casey Mulligan, chief counsel at the Small Business Administration's Office of Advocacy, testifies on regulatory flexibility and reform before the House Small Business Committee.
US FDA to limit regulation of health and fitness wearables, commissioner says
The U.S. Food and Drug Administration said on Tuesday that it will limit regulation of wearable devices and software designed to support healthy lifestyles, issuing new guidance to clarify its regulatory approach.
Why health care CFOs are caught between AI pressure and governance risk
A new report finds governance gaps, regulatory exposure, and thin margins are complicating AI investment decisions.
One of N.J.’s last independent hospitals to join major health chain, 3 years after failed merger with rival
The agreement still needs to go through state and regulatory approvals.
Denver Health, Children's Hospital Colorado suspend gender-affirming care for youth
In response to regulatory actions by the U.S. Department of Health and Human Services, Denver Health and Children's Hospital Colorado say they have suspended all medical gender-affirming care for patients under 18.
Inside Gaming: Strip operator extending discounts into 2026
Plus, Atlantic City casinos won more than $236.8 million from gamblers in November, a year-over-year increase of 5.7 percent, according to state regulatory data.
2025 Health Care Delivery Snapshot
In 2025, MSMS advanced physician interests through advocacy, collaboration, and direct support on payer, legal, and regulatory issues. MSMS submitted letters, individually or jointly, to federal and state legislators and regulators on issues including Medicare payment, Medicaid funding, telehealth, physician-owned hospitals, downcoding policies, out-of-network care, substance use disorder home health, ACA premium tax credits, immunizations, and medical student loans. MSMS met...
Westerman’s SPEED Act accelerates to the Senate - Talk Business & Politics
U.S. Rep. Bruce Westerman, R-Hot Springs, has been working on a regulatory reform bill for years, and this week, he saw the culmination of his efforts take a giant leap...
FY26 FDA Broad Agency Announcement: Advanced Research and Development of Regulatory Science
FY26 FDA Broad Agency Announcement: Advanced Research and Development of Regulatory Science / cancer, FDA, FY26, Headlines, OncoDaily, Oncology
Ford shows the consequences of whiplash politics
Big shifts in political power tend to lead to extreme regulatory swings, too.
Netflix CEOs Defend Warner Bros. Deal in Memo to Employees: ‘We See This as a Win for the Entertainment Industry, Not the End of It’
Ted Sarandos and Greg Peters, the co-CEOs of Netflix, issued a memo to staffers that conveyed their belief that the company's deal to buy Warner Bros. and HBO Max will withstand a counterattack by David Ellison's Paramount Skydance and will clear regulatory hurdles.
How Investors May Respond To Elevance Health (ELV) Expanding AI Assistant Access And Adding Schulman To Board
Elevance Health recently expanded access to its AI-powered Virtual Assistant for about 22 million commercial members and announced that Amy Schulman, a senior healthcare executive and governance expert, will join its board and sit on the Audit and Finance Committees in January 2026. Together, these moves highlight Elevance Health’s push to blend digital-first member support with strengthened board oversight in healthcare innovation and regulatory strategy. We’ll now examine how the broader...
12 Days of Regulatory Insights: Day 6 – Sports Wagering, Player Proposition Bets, and Prediction Market Battles
In this episode of our special 12 Days of Regulatory Insights podcast series, Stephen Piepgrass is joined by Cole White from our RISE Practice Group's